OTCPK:GBGPF - Post by User
Post by
thorgb1on Jul 17, 2017 9:35am
164 Views
Post# 26475631
Brent Zettl buying big......
Brent Zettl buying big......
CanniMed Therapeutics Inc (CMED) Director Buys C$395,500.00 in Stock
July 16th, 2017 -
By Doug Wharley - 0 comments CanniMed Therapeutics Inc (TSE:CMED) Director Brenton Harold Zettl acquired 50,000 shares of CanniMed Therapeutics stock in a transaction that occurred on Thursday, June 15th. The shares were purchased at an average cost of C$7.91 per share, for a total transaction of C$395,500.00.
Brenton Harold Zettl also recently made the following trade(s):
- On Wednesday, June 28th, Brenton Harold Zettl purchased 7,300 shares of CanniMed Therapeutics stock. The shares were bought at an average cost of C$7.99 per share, with a total value of C$58,327.00.
- On Tuesday, June 27th, Brenton Harold Zettl acquired 7,300 shares of CanniMed Therapeutics stock. The stock was acquired at an average cost of C$7.99 per share, with a total value of C$58,327.00.
Shares of CanniMed Therapeutics Inc (CMED) opened at 9.45 on Friday. The company’s 50-day moving average is $8.78 and its 200-day moving average is $10.82. CanniMed Therapeutics Inc has a 12-month low of $7.32 and a 12-month high of $13.35. The firm’s market capitalization is $214.58 million.